Yutian Wei

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

Journal: Oncogene

Published: May 21, 2024

Association Between Geriatric Nutritional Risk Index and Critically Ill Patients With Pressure Injury: Analysis of the MIMIC-IV Database.

Association Between Geriatric Nutritional Risk Index and Critically Ill Patients With Pressure Injury: Analysis of the MIMIC-IV Database.

Journal: Journal of clinical nursing

Published: February 08, 2024

Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastoma.

Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastoma.

Journal: Bioscience reports

Published: August 16, 2023

O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.

Journal: Oncogene

Published: June 23, 2023

Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma.

Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma.

Journal: Journal for immunotherapy of cancer

Published: August 30, 2022

Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2/HO-1 pathway.

Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2/HO-1 pathway.

Journal: Journal of neuroinflammation

Published: November 02, 2021

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis.

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis.

Journal: Journal of Cancer

Published: May 28, 2021

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.

Journal: Neuro-oncology

Published: September 14, 2020

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.

Journal: Theranostics

Published: April 15, 2020

Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.

Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.

Journal: Bioscience reports

Published: February 28, 2020

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism.

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism.

Journal: Cancer cell international

Published: October 20, 2019

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.

Journal: Molecular cancer

Published: August 15, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026